Smiling white caucasian man in a disposable protective surgical mask in a period of coronavirus covid-19 pandemic is walking on the street.

Moderna COVID-19 Vaccine in Transplant Patients Study

Ages

18 and Over

Location

Phoenix, AZ

Compensation

Up to $1,520*
Smiling white caucasian man in a disposable protective surgical mask in a period of coronavirus covid-19 pandemic is walking on the street.

COVID-19 Vaccine Trials in Phoenix

Aventiv Research is currently participating in ModernaTX’s mRNA-1273 COVID-19 vaccine study at our Phoenix, AZ location. Moderna’s COVID-19 mRNA-1273 Vaccine has received Emergency Use Authorization in adults 18 years old and over from the U.S. Food and Drug Administration (FDA). The effectiveness of the mRNA-1273 study vaccine in people who have received a solid organ transplant is not known which is why we are conducting this research study.

Enroll Now

Moderna COVID-19 Vaccine in Transplant Patients Study

The primary objective of this clinical trial is to evaluate the safety and immunogenicity of Moderna’s mRNA-1273 vaccine for the prevention of COVID-19 in participants who have had a solid organ transplant, kidney or liver.

We are specifically looking for volunteers who are:

  • Adults 18 years old and over
  • Kidney or liver (single organ) transplant recipients who are at least 6 months after transplantation
  • Medically stable for at least 3 months prior to joining the study

As a part of our ongoing commitment to protect your health and safety, we’re practicing enhanced safety measures at our clinical research sites.

Ready to Volunteer?

Volunteer today to see if you qualify for our COVID-19 vaccine clinical research study. *Qualified volunteers may be compensated for time and travel.